The Global Advanced Research Journal of Biotechnology (GARJB)
provides rapid publication (monthly) of articles in all
areas of the subject.
Global Advanced Research Journal of Biotechnology (GARJB) publishes
original scientific articles, reviews and short
communications that are not under consideration for
The journal publishes papers based on original research that
are judged by two international reviewers, to make a
substantial contribution in the field. It aims at rapid
publication of high quality research results while
maintaining rigorous peer review process.
The Journal welcomes the submission of manuscripts that meet
the general criteria of significance and scientific
excellence. Papers will be published approximately one month
Papers must be submitted with the understanding that they
have not been published elsewhere (except in the form of an
abstract or as part of a published lecture, review, or
thesis) and are not currently under consideration by another
journal published by GLOBAL ADVANCED RESEARCH JOURNALS or
any other publisher.
The submitting (Corresponding) author is responsible for
ensuring that the article's publication has been approved by
all the other coauthors. It is also the authors'
responsibility to ensure that the articles emanating from a
particular institution are submitted with the approval of
the necessary institution. Only an acknowledgment from the
editorial office officially establishes the date of receipt.
Further correspondence and proofs will be sent to the
corresponding author(s) before publication unless otherwise
indicated. It is a condition for submission of a paper that
the authors permit editing of the paper for readability. All
enquiries concerning the publication of accepted papers
should be addressed to
Electronic submission of manuscripts is strongly encouraged,
provided that the text, tables, and figures are included in
a single Microsoft Word file (preferably in Arial font).
Submit manuscripts as e-mail attachment to the editorial
firstname.lastname@example.org. A manuscript
number will be mailed to the corresponding author same day
or within 48hours.
The cover letter should include the corresponding author's
full address and telephone/fax numbers and should be in an
e-mail message sent to the editor, with the file, whose name
should begin with the first author's surname, as an
attachment. The author(s) may also suggest two to four
reviewers for the manuscript (GARJB may designate other
Global Advanced Research Journal of Biotechnology (GARJB) will
only accept manuscripts submitted as e-mail attachments.
Three types of manuscripts may be submitted:
Regular Articles: original full-length research papers which
have not been published previously, except in a preliminary
form. These should describe new and carefully confirmed
findings, and experimental procedures should be given in
sufficient detail for others to verify the work. The length
of a full paper should be the minimum required to describe
and interpret the work clearly.
Short Communications: A Short Communication is suitable for
recording the results of complete small investigations or
giving details of new models or hypotheses, innovative
methods, techniques or apparatus. The style of main sections
need not conform to that of full-length papers. Short
communications are 2 to 4 printed pages (about 6 to 12
manuscript pages) in length.
Reviews: Submissions of reviews and perspectives covering
topics of current interest are welcome and encouraged.
Reviews should be concise and no longer than 4 to 6 printed
pages (about 12 to 18 manuscript pages). Reviews are also
All manuscripts are reviewed by an editor and members of the
editorial board or qualified outside reviewers. Decisions
will be made as rapidly as possible, and the journal strives
to return reviewers’ comments to authors within 3 weeks. The
editorial board will re-review manuscripts that are accepted
pending revision. The Editorial Board decides acceptance or
rejection of a paper, and appeals are not accepted. It is
the goal of the (GARJB) to publish manuscripts within 8 weeks
All portions of the manuscript must be typed double-spaced
and all pages numbered starting from the title page.
The Title should be a brief phrase describing the contents
of the paper. The Title Page should include the authors'
full names and affiliations, the name of the corresponding
author along with phone, fax and e-mail information. Present
addresses of authors should appear as a footnote.
The Abstract should be informative and completely
self-explanatory, briefly present the topic, state the scope
of the experiments, indicate significant data, and point out
major findings and conclusions. The abstract should be 100
to 250 words in length. Complete sentences, active verbs,
and the third person should be used, and the abstract should
be written in the past tense. Standard nomenclature should
be used and abbreviations should be avoided. No literature
should be cited.
Following the abstract, about 3 to 10 key words that will
provide indexing references should be listed. A list of
non-standard Abbreviations should be added. In general,
non-standard abbreviations should be used only when the full
term is very long and used often. Each abbreviation should
be spelt out and introduced in parentheses the first time it
is used in the text. Only recommended SI units should be
used. Authors should use the solidus presentation (mg/ml).
Standard abbreviations (such as ATP and DNA) need not be
The Introduction should provide a clear statement of the
problem, the relevant literature on the subject, and the
proposed approach or solution. It should be understandable
to colleagues from a broad range of scientific disciplines.
Materials and Methods should be complete enough to allow
experiments to be reproduced. However, only truly new
procedures should be described in detail; previously
published procedures should be cited, and important
modifications of published procedures should be mentioned
briefly. Capitalize trade names and include the
manufacturer's name and address. Subheadings should be used.
Methods in general use need not be described in detail.
Results should be presented with clarity and precision. The
results should be written in the past tense when describing
findings in the author(s)'s experiments. Previously
published findings should be written in the present tense.
Results should be explained, but largely without referring
to the literature. Discussion, speculation and detailed
interpretation of data should not be included in the results
but should be put into the discussion section.
The Discussion should interpret the findings in view of the
results obtained in this and in past studies on this topic.
State the conclusions in a few sentences at the end of the
paper. The Results and Discussion sections can include
subheadings, and when appropriate, both sections can be
The Acknowledgments of people, grants, funds, etc should be
Tables should be kept to a minimum and be designed to be as
simple as possible. Tables are to be typed double-spaced
throughout, including headings and footnotes. Each table
should be on a separate page, numbered consecutively in
Arabic numerals and supplied with a heading and a legend.
Tables should be self-explanatory without reference to the
text. The details of the methods used in the experiments
should preferably be described in the legend instead of in
the text. The same data should not be presented in both
table and graph forms or repeated in the text.
Figure legends should be typed in numerical order on a
separate sheet. Graphics should be prepared using
applications capable of generating high resolution GIF,
TIFF, JPEG or PowerPoint before pasting in the Microsoft
Word manuscript file. Tables should be prepared in Microsoft
Word. Use Arabic numerals to designate figures and upper
case letters for their parts (Figure 1). Begin each legend
with a title and include sufficient description so that the
figure is understandable without reading the text of the
manuscript. Information given in legends should not be
repeated in the text.
References: In the text, a reference identified by means of
an author‘s name should be followed by the date of the
reference in parentheses. When there are more than two
authors, only the first author‘s name should be mentioned,
followed by ’et al‘. In the event that an author cited has
had two or more works published during the same year, the
reference, both in the text and in the reference list,
should be identified by a lower case letter like ’a‘ and ’b‘
after the date to distinguish the works.
Bright (2005), Matins et al. (2008), (Kelebeni, 2000),
(Williams and Garry, 1992), (Chege, 1998; Bush, 2000a,b;
Harry, 1989,1980), (Celvin et al., 2001)
References should be listed at the end of the paper in
alphabetical order. Articles in preparation or articles
submitted for publication, unpublished observations,
personal communications, etc. should not be included in the
reference list but should only be mentioned in the article
text (e.g., A. University of Abuja, Gwagwalada, Nigeria,
personal communication). Journal names are abbreviated
according to Chemical Abstracts. Authors are fully
responsible for the accuracy of the references.
Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M,
Stone TW, Darlington LG (2005). Tryptophan metobolism and
oxidative stress in patients with Huntington's disease. N.J.
Neurochem. 93: 611-623.
Charles AL, Sriroth K, Huang TC (2005). Proximate
composition,mineral contents, hydrogen cyanide and phytic
acid of 5 cassava genotypes. Food Chem. 92: 615-620.
Booth M, Bundy D.A, Albonico P, Chwaya M, Alawi K (1998).
Associations among multiple geohelminth infections in school
chilldren from Pemba Island. Parasitol. 116: 85-93.0.
Stanislawski L, Lefeuvre M, Bourd K, Sohelli-Majd E,
Goldberg M, Perianin A (2003). TEGDMA-induceed toxicity inn
human fibroblasts is associated with early drastic
glutathione depletion with subsequent production of oxygen
reactive species. J. Biomed. Res. 66: 476-8.
Pitout JDD, Church DL, Gregson DB, Chow BL, McCracken M,
Mulvey M, Laupland KB (2007). Molecular epidemiology of CTXM-producing
Escherichia coli in the Calgary Health Region: emergence of
CTX-M-15-producing isolates. Antimicrob. Agents Chemother.
Short Communications are limited to a maximum of two figures
and one table. They should present a complete study that is
more limited in scope than is found in full-length papers.
The items of manuscript preparation listed above apply to
Short Communications with the following differences: (1)
Abstracts are limited to 100 words; (2) instead of a
separate Materials and Methods section, experimental
procedures may be incorporated into Figure Legends and Table
footnotes; (3) Results and Discussion should be combined
into a single section.
Proofs and Reprints: Electronic proofs will be sent (e-mail
attachment) to the corresponding author as a PDF file. Page
proofs are considered to be the final version of the
manuscript. With the exception of typographical or minor
clerical errors, no changes will be made in the manuscript
at the proof stage. Because the (GARJB) will be published
freely online to attract a wide audience), authors will have
free electronic access to the full text (in PDF) of the
article. Authors can freely download the PDF file from which
they can print unlimited copies of their articles.
Copyright: Submission of a manuscript implies; that the work
described has not been published before (except in the form
of an abstract or as part of a published lecture, or thesis)
that it is not under consideration for publication
elsewhere; that if and when the manuscript is accepted for
publication, the authors agree to automatic transfer of the
copyright to the publisher.
Fees and Charges: Authors are required to pay a $450
processing fee. Publication of an article in the
Global Advanced Research Journal of Biotechnology (GARJB) is not contingent
upon the author's ability to pay the charges. Neither is
acceptance to pay the processing fee a guarantee that the
paper will be accepted for publication. Authors may still
request (in advance) that the editorial office waive some of
the processing fee under special circumstances.